Acta Anatomica Sinica ›› 2021, Vol. 52 ›› Issue (4): 561-566.doi: 10.16098/j.issn.0529-1356.2021.04.010

• Cell and Molecules Biology • Previous Articles     Next Articles

Effect of osteoclast-derived apoptotic body microR-30a on osteogenic activity

  

  1. 1.Orthopaedics Department, People’s Hospital of Lujiang County,  Anhui Lujiang 231500, China; 2.Institute of Integrated Chinese and Western Medicine, the Affiliated Hospital of Jiangnan University, Jiangsu Wuxi 214041, China
  • Received:2020-04-01 Revised:2020-06-12 Online:2021-08-06 Published:2021-08-06
  • Contact: YUAN Feng-lai E-mail:bjjq88@163.com

Abstract:

Objective  To explore that whether apoptotic bodies released by osteoclasts mediate osteogenic activity.    Methods  The osteoclasts were induced from mouse(n=10)bone marrow monocytes in vitro, and were identified by tartrate resistant acid phosphatase (TRAP) staining, F-actin, and DAPI double labeling immunofluorescence. The Co-culture system of osteoclasts and mouse osteoblasts MC-3T3E1 was established. The apoptosis of osteoclasts was analyzed by DNA fragment ELISA. Immunoblotting of apoptotic body markers was investigated. Real-time PCR analysis of bone formation markers was tested. MiRNA expression profiling of apoptotic body was identisfied.    Results  Alendronate (ALN) 100 μmol/L induced osteoclast apoptosis and caused apoptotic body release from osteoclasts. The expression of C3b and annexin Ⅴ protein was enhanced by ALN; the expression of C3b in osteoclasts was negatively correlated with the activity of osteoblasts; the microarray screening of apoptotic body showed that miR-30a was correlated with bone formation markers and serum alkaline phosphatase (ALP).    Conclusion  Osteoclast-derived apoptotic body miR-30a can inhibit the activity of osteoblasts. Apoptotic body may participate in the dialogue between osteoclasts and osteoblasts.

Key words: Osteoclast, Apoptotic body, Osteoblast, Osteoporosis, Western blotting, Mouse

CLC Number: